Literature DB >> 15462488

Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations.

S R Johnson1, P J Harvey, J S Floras, M Iwanochko, D Ibanez, D D Gladman, M Urowitz.   

Abstract

Our objective was to compare brachial artery endothelium dependent and independent vasodilation in lupus patients and healthy females, by means of high-resolution noninvasive brachial artery ultrasound. Endothelially mediated vasodilation was estimated noninvasively by examination of brachial artery responses to postischemic reactive hyperemia and endothelial independent vasodilation from response to sublingual glycerlynitrate (GTN) using high-resolution external vascular ultrasound. Five patients with known coronary artery disease (CAD), five with subclinical CAD, five with no CAD and five control subjects were assessed. Endothelium dependent vasodilation was significantly blunted in lupus patients with CAD as compared with healthy female controls (0.11 versus 11.1%, P = 0.018). Corresponding values for lupus patients with subclinical CAD and no CAD were 11 and 9.6%, respectively. For each subject, endothelium dependent vasodilation (EDV) was related to endothelium independent vasodilation (EIV) to adjust for varying vascular smooth muscle responses to GTN in individual subjects. This ratio was markedly depressed in lupus patients with CAD as compared with control subjects (0.12 versus 1.15). The corresponding EDV/EIV ratios for patients with subclinical CAD and no CAD were similar at 0.69 and 0.65, respectively. The conclusion was that flow mediated vasodilation in lupus patients with coronary artery disease is markedly depressed as compared to healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15462488     DOI: 10.1191/0961203304lu1072oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  17 in total

1.  A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus.

Authors:  J Aizer; E W Karlson; L B Chibnik; K H Costenbader; D Post; M H Liang; V Gall; M D Gerhard-Herman
Journal:  Lupus       Date:  2009-03       Impact factor: 2.911

2.  Omega-3: a double-edged sword for autoimmune diseases.

Authors:  Guo-Cui Wu; Xiao-Di Xu; Qiong Huang; Hua Wu
Journal:  Rheumatol Int       Date:  2013-09-07       Impact factor: 2.631

3.  Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus.

Authors:  Sokha Nhek; Robert Clancy; Kristen A Lee; Nicole M Allen; Tessa J Barrett; Emanuela Marcantoni; Janet Nwaukoni; Sara Rasmussen; Maya Rubin; Jonathan D Newman; Jill P Buyon; Jeffrey S Berger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

4.  Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.

Authors:  Victoria L Wolf; Taylor L Phillips; Erin B Taylor; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

Review 5.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

6.  High dietary fat promotes visceral obesity and impaired endothelial function in female mice with systemic lupus erythematosus.

Authors:  Emily L Gilbert; Michael J Ryan
Journal:  Gend Med       Date:  2011-04

7.  Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosus.

Authors:  Marcia Venegas-Pont; Keisa W Mathis; Radu Iliescu; William H Ray; Porter H Glover; Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-07       Impact factor: 3.619

8.  Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients.

Authors:  Gregory Katz; Nathaniel R Smilowitz; Ashira Blazer; Robert Clancy; Jill P Buyon; Jeffrey S Berger
Journal:  Mayo Clin Proc       Date:  2019-07-11       Impact factor: 7.616

9.  Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.

Authors:  Peter E Westerweel; Remco K M A C Luijten; Imo E Hoefer; Hein A Koomans; Ronald H W M Derksen; Marianne C Verhaar
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

10.  Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus.

Authors:  Kayode J Bello; Hong Fang; Parastoo Fazeli; Waleed Bolad; Mary Corretti; Laurence S Magder; Michelle Petri
Journal:  Rheumatol Int       Date:  2013-07-02       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.